Quarterly report pursuant to Section 13 or 15(d)

PRIOR PERIOD RESTATEMENT (Tables)

v3.8.0.1
PRIOR PERIOD RESTATEMENT (Tables)
3 Months Ended
Feb. 28, 2018
Condensed Financial Statements [Table Text Block]
  Quarter ended
  February 28, 2017
     
  Prior to  
  Restatement Restated
  $ $
Consolidated Balance Sheet:    
Secured convertible debentures, net of deferred financing costs 1,615,201 1,350,487
Derivative liabilities 467,671 606,991
Total Liabilities 2,523,621 2,398,227
Accumulated deficit (28,563,975) (28,438,581)
Total Stockholders' Deficiency (1,186,801) (1,061,407)
     
Consolidated Statement of Operations and
Comprehensive Loss:
   
     
Foreign currency translation loss 13,156 13,822
Selling, general and administration 523,613 479,160
Total Operating Expenses 548,741 504,954
Loss from Operations (529,419) (485,632)
Change in fair value of derivative liabilities 421,379 571,648
Accretion - (68,662)
Loss before Income Taxes (265,362) (139,968)
Net Loss (265,362) (139,968)
Comprehensive Loss (243,209) (117,815)
Loss per share-basic and diluted (0.004) (0.002)
     
Consolidated Statement of
Cash Flows
Three months ended
  February 28, 2017
Net Loss (265,362) (139,968)
Adjustment for: Foreign currency translation 13,156 13,822
Amortization of debt discount 44,453 68,662
Change in fair value of derivative liabilities (421,379) (571,648)
Net cash used in operating activities (477,651) (477,651)